Related Experiment Video
Updated: Jan 26, 2026
07:30
Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
4.3K
Pilot Experience with ABO-Incompatible Kidney Transplantation as a Second Transplant
Junji Uchida1, Akihiro Kosoku2, Kazuya Kabei2
1Department of Urology, Osaka City University Graduate School of Medicine, Osaka, Japan, m9492120@msic.med.osaka-cu.ac.jp.
Urologia Internationalis
|April 17, 2019
Summary
Second kidney transplants using ABO-incompatible donors show promising results, offering a viable option for patients with failing initial grafts. This approach achieved 100% patient and graft survival in a small study group.
Area of Science:
- Nephrology
- Transplantation Immunology
Background:
- Long-term survival for kidney transplant recipients remains challenging despite immunosuppression advances.
- Increasing rates of initial graft failure necessitate effective second transplant options.
- Second kidney transplantation offers better survival than dialysis after initial graft loss.
Purpose of the Study:
- To evaluate the feasibility and outcomes of ABO-incompatible kidney transplantation as a second transplant.
- To analyze immunosuppressive strategies and donor-specific antibody status in this patient population.
Main Methods:
- Retrospective analysis of three patients undergoing second ABO-incompatible kidney transplantation with living donors.
- Focus on immunosuppressive regimens, pre-transplant donor-specific antibody levels, and patient/graft survival.
Main Results:
- All three patients successfully received ABO-incompatible second kidney transplants.
- Follow-up periods ranged from 24 to 141 months.
- Achieved 100% patient and graft survival rates.
Conclusions:
- ABO-incompatible kidney transplantation is a potentially acceptable treatment for patients requiring second renal replacement therapy.
- This approach offers a successful alternative to dialysis after initial graft failure.
Related Concept Videos
01:28Kidney Transplant I: Introduction
386
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
386
01:26Kidney Transplant II: Surgical Procedure
379
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
379
01:16Kidney Transplant III: Nursing Management
359
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
359
01:24Tissue Transplantation
947
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
947
01:12The ABO Blood Group
4.8K
The ABO blood group system is a critical element of transfusion medicine, essential for determining blood compatibility in transfusions and organ transplants. It is based on specific antigens, or agglutinogens, present on the surface of red blood cells (RBCs) and corresponding antibodies, or agglutinins, in the blood plasma.
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...
4.8K
01:22Bone Marrow Sampling and Transplants
989
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
989